BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hunter P, Fryhofer SA, Szilagyi PG. Vaccination of Adults in General Medical Practice. Mayo Clin Proc 2020;95:169-83. [PMID: 31902413 DOI: 10.1016/j.mayocp.2019.02.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Ellingson MK, Oliveira CR, Sheth SS, Sullivan EL, Torres A, Shapiro ED, Niccolai LM. Patterns of recommended vaccine receipt among women ages 24-45 years: a cross-sectional analysis. BMC Public Health 2021;21:1283. [PMID: 34193100 DOI: 10.1186/s12889-021-11340-4] [Reference Citation Analysis]
2 Patterson BJ, Buck PO, Curran D, Van Oorschot D, Carrico J, Herring WL, Zhang Y, Stoddard JJ. Estimated Public Health Impact of the Recombinant Zoster Vaccine. Mayo Clin Proc Innov Qual Outcomes 2021;5:596-604. [PMID: 34195552 DOI: 10.1016/j.mayocpiqo.2021.03.006] [Reference Citation Analysis]
3 Sun W, Gao H, Luo Y, Zheng H, Liao X, Xiong D, Xiao L. Management of Immunity Alteration-Induced Chronic Pain During the Coronavirus Disease-2019 (COVID-19) Pandemic. Front Microbiol 2020;11:572318. [PMID: 33072033 DOI: 10.3389/fmicb.2020.572318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Eisenhauer L, Hansen BR, Pandian V. HPV immunization among young adults (HIYA!) in family practice: A quality improvement project. J Adv Nurs 2021. [PMID: 34806202 DOI: 10.1111/jan.15090] [Reference Citation Analysis]
5 Harpaz R. The Effectiveness of Recombinant Zoster Vaccine: Observations in the Wild. Clin Infect Dis 2021;73:957-60. [PMID: 33580235 DOI: 10.1093/cid/ciab130] [Reference Citation Analysis]
6 Gatwood J, Renfro C, Hagemann T, Chiu CY, Kapan S, Frederick K, Hohmeier KC. Facilitating pneumococcal vaccination among high-risk adults: Impact of an assertive communication training program for community pharmacists. J Am Pharm Assoc (2003) 2021;61:572-580.e1. [PMID: 33935021 DOI: 10.1016/j.japh.2021.04.011] [Reference Citation Analysis]
7 Redondo Margüello E, Trilla A, Munguira ILB, Jaramillo López-Herce A, Cotarelo Suárez M. Knowledge, attitudes, beliefs and barriers of healthcare professionals and adults ≥ 65 years about vaccine-preventable diseases in Spain: the ADult Vaccination drIverS and barriErs (ADVISE) study. Hum Vaccin Immunother 2022;:1-10. [PMID: 35172691 DOI: 10.1080/21645515.2021.2025007] [Reference Citation Analysis]
8 de Oliveira Costa J, Gianacas C, Beard F, Gonzalez-Chica D, Chidwick K, Osman R, MacIntyre CR, Havard A. Cumulative annual coverage of meningococcal B vaccination in Australian general practice for three at-risk groups, 2014 to 2019. Hum Vaccin Immunother 2021;17:3692-701. [PMID: 34047673 DOI: 10.1080/21645515.2021.1923349] [Reference Citation Analysis]
9 Zhang W, He C, Taiar R. Clinical Efficacy of Pulsed Radiofrequency Combined with Intravenous Lidocaine Infusion in the Treatment of Subacute Herpes Zoster Neuralgia. Pain Research and Management 2022;2022:1-14. [DOI: 10.1155/2022/5299753] [Reference Citation Analysis]